Redeye leaves a comment following OncoZenge’s announcement yesterday of having entered a SEK30.2m investment agreement with the Chinese pharmaceutical company Yangtian Pharma. We are encouraged to see that the company has secured essential funding and believe that this agreement marks a significant milestone.
LÄS MER